How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
COVID-19 Vaccine Packaging and Delivery Devices Market
- By Packaging Type: Vials, Pre-filled Syringes, Cartridges, Ampoules, Multi-dose Vials
- By Delivery Device Type: Auto-Injectors, Needle-Free Injectors, Prefilled Syringes, Jet Injectors, Pen Injectors
- By Material Type: Glass, Plastic, Polymer Composite
- By Cold Chain Packaging: Insulated Boxes, Thermal Blankets, Phase Change Materials (PCM), Refrigerated Containers
- By End User: Hospitals, Clinics, Vaccination Centers, Pharmacies
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Vials leads By Packaging Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the COVID-19 Vaccine Packaging and Delivery Devices Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Packaging Type 5
Delivery Device Type 5
Material Type 3
Cold Chain Packaging 4
End User 4
Companies profiled
Pfizer Inc.
Moderna Inc.
Johnson & Johnson (Janssen Pharmaceuticals)
AstraZeneca plc
Sanofi S.A.
GlaxoSmithKline plc
Becton
Dickinson and Company (BD)
SCHOTT AG
West Pharmaceutical Services Inc.
Catalent Inc.
Gerresheimer AG
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Pfizer Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Moderna Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Johnson & Johnson (Janssen Pharmaceuticals)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →AstraZeneca plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sanofi S.A.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →GlaxoSmithKline plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Dickinson and Company (BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →SCHOTT AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →West Pharmaceutical Services Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Catalent Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Gerresheimer AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Nipro Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Sartorius AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Stevanato Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Vetter Pharma International GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,513M by 2033 · 9.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Vials43.7
- Pre-filled Syringes18.6
- Cartridges10.0
- Ampoules18.1
- Multi-dose Vials9.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$743.7M → $1,565M · 9.7%
Europe$518.3M → $972.0M · 8.2%
Asia Pacific$473.3M → $960.1M · 9.2%
Latin America$293.0M → $623.7M · 9.9%
Middle East and Africa$225.4M → $422.0M · 8.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.032026
9.032027
9.052028
9.052029
9.072030
9.072031
9.092032
9.102033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Pfizer Inc.10.4
- Moderna Inc.23.2
- Johnson & Johnson (Janssen Pharmaceuticals)16.6
- AstraZeneca plc7.9
- Sanofi S.A.5.4
- GlaxoSmithKline plc8.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Packaging Type19.8%
Delivery Device Type31.3%
Material Type19.1%
Cold Chain Packaging14.5%
End User15.3%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.5
- Europe21.4
- Asia Pacific21.1
- Latin America13.7
- Middle East and Africa9.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Pfizer Inc. | 78 | 78 | 89 | 89 | 96 | 95 | 88 |
| Moderna Inc. | 93 | 82 | 86 | 72 | 84 | 85 | 84 |
| Johnson & Johnson (Janssen Pharmaceuticals) | 79 | 78 | 78 | 64 | 69 | 66 | 72 |
| AstraZeneca plc | 60 | 63 | 69 | 62 | 58 | 82 | 66 |
| Sanofi S.A. | 60 | 59 | 51 | 58 | 76 | 66 | 62 |
| GlaxoSmithKline plc | 56 | 50 | 52 | 48 | 68 | 68 | 57 |
| Becton | 51 | 44 | 47 | 46 | 60 | 64 | 52 |
| Dickinson and Company (BD) | 37 | 38 | 40 | 36 | 58 | 54 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Pfizer Inc.
- Moderna Inc.
- Johnson & Johnson (Janssen Pharmaceuticals)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Pfizer Inc. | ✓ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Moderna Inc. | ✓ | ✓ | ✓ | ◐ | ◐ | ✓ |
| Johnson & Johnson (Janssen Pharmaceuticals) | ◐ | ✓ | ✓ | − | ✓ | ◐ |
| AstraZeneca plc | ◐ | ◐ | ◐ | − | − | ◐ |
| Sanofi S.A. | − | − | ◐ | ◐ | ✓ | ◐ |
| GlaxoSmithKline plc | ◐ | ◐ | − | − | ◐ | ◐ |
| Becton | − | − | ◐ | ◐ | ◐ | − |
| Dickinson and Company (BD) | − | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Pfizer Inc.88
2Moderna Inc.84
3Johnson & Johnson (Janssen Pharmaceuticals)72
4AstraZeneca plc66
5Sanofi S.A.62
6GlaxoSmithKline plc57
7Becton52
8Dickinson and Company (BD)44
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Pfizer Inc.Moderna Inc.
Challenger1
Strong scale, closing on the leaders.
Johnson & Johnson (Janssen Pharmaceuticals)
Contender3
Focused players with pockets of strength.
AstraZeneca plcSanofi S.A.GlaxoSmithKline plc
Niche2
Specialists in a single segment or region.
BectonDickinson and Company (BD)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Packaging Type in North America, then scale across COVID-19 Vaccine Packaging and Delivery Devices Market — a $174M beachhead inside a $2.75B market.
Beachhead (SOM)$174Mobtainable near-term
Serviceable (SAM)$1.09Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Vials
Best fit — highest urgency & budget in Packaging Type.
Economic buyer80 fit
Pre-filled Syringes
Strong fit — clear ROI and a fast path to value.
End user70 fit
Cartridges
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Packaging Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Delivery Device Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Material Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel26%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Packaging Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win COVID-19 Vaccine Packaging and Delivery Devices Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified21%
Evaluation12%
Closed-won6%
$12.2KCAC
$54KLTV
4.4:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
COVID-19 Vaccine Packaging and Delivery Devices Market is a durable-growth opportunity — $2.87B by 2033, compounding at 7.1%.
TAM · 2025$1.66Btoday
TAM · 2033$2.87Bforecast
CAGR7.1%2027–2033
Cumulative$19.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.87BTotal addressable market
SAM$1.13BServiceable available market
SOM$216MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.1% CAGR
Demand compounds through 2033, outpacing GDP across Packaging Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Packaging Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.87BLarge & growingTAM by 2033 at 7.1% CAGR
$1.13BServiceable nowreachable with today’s model
$216MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.24BBear4.6% CAGR
$2.87BBase7.1% CAGR
$3.68BBull9.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Delivery Device Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
COVID-19 Vaccine Packaging and Delivery Devices Market — a $7.56B market by 2033. Plan: grow share from 6.9% to 11.6%.
Market size · 2033$7.56Btotal addressable
Market CAGR7.7%2027–2033
Target share11.6%from 6.9% today
Revenue ambition$877Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.9% | 11.6% | Behind |
| Revenue | $525M | $877M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 28.4% | 40.9% | On track |
| Customer retention | 89.8% | 95.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Packaging Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Delivery Device Type capability
A defensible second engine — invest in Delivery Device Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Packaging Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Delivery Device Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $112M capacity & capability investment
- Greenlight bolt-on M&A in Delivery Device Type
- Authorise North America expansion plan
- Fund R&D program for Packaging Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the COVID-19 Vaccine Packaging and Delivery Devices Market conversation — a $7.14B market you can size, segment and defend in minutes.
Market size · 2033$7.14Btotal opportunity
Growth8.9%CAGR to 2033
Addressable buyers1,303+accounts in scope
Typical ROI5.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Packaging Type
Goal Grow share in Packaging Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.4×return on cost, year one
< 2 mopayback period
$68K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Pfizer Inc.Moderna Inc.Johnson & Johnson (Janssen Pharmaceuticals)AstraZeneca plcSanofi S.A.GlaxoSmithKline plcBectonDickinson and Company (BD)+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your COVID-19 Vaccine Packaging and Delivery Devices Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
COVID-19 Vaccine Packaging and Delivery Devices Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →COVID-19 Vaccines & Boosters Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportCOVID-19 Waste Disposal Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportCOVID-testing Swab Kits Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportCow Dung Dewater Machine Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportCow Milk Infant Formula Sales Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportCow Milk Protein-based Formulas Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportCoworking Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportCoworking Spaces Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportCowpea Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportCowpeas Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportCp Coke Market
Market size, share, segmentation and regional forecast.
$361M market · 2025 base year
View reportCP Pallets Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.